Delivery Order SPE2DB24D2212-SPE2DB25FHQLN
- Not listed
- The Defense Logistics Agency awarded a $1,904.63 firm fixed price delivery order to AmerisourceBergen Drug Corp on September 4, 2025, for the supply of Mounjaro 5 mg/0.5 mL pens (0.5 mL). This competitively awarded, non-set-aside contract is scheduled for completion by September 5, 2025, with performance occurring at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop...
- The Defense Logistics Agency awarded a $2,448.81 firm fixed-price delivery order to AmerisourceBergen Drug Corp on September 9, 2025, for the supply of Mounjaro 5 mg/0.5 mL pens (0.5 mL units). The contract is scheduled for completion by September 10, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. This delivery order was competitively awarded with no set-aside designation and represents a child contract under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a $8,703.85 firm fixed price delivery order to AmerisourceBergen Drug Corp on August 11, 2025, for the supply of Mounjaro 5 mg/0.5 ml pens. The contract, which is non-set-aside and competitively awarded, has an ultimate completion date of August 12, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery...
- The Defense Logistics Agency awarded a $2,776.41 delivery order to AmerisourceBergen Drug Corp for the supply of Mounjaro 5 mg/0.5 mL pens on September 22, 2025, with completion targeted for September 23, 2025. This is a firm fixed price, non-set-aside contract with performance taking place at AmerisourceBergen's facility in Conshohocken, Pennsylvania. The delivery order falls under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at...
- The Defense Logistics Agency awarded a delivery order valued at $1,225.77 to AmerisourceBergen Drug Corp on July 29, 2025, for the supply of Mounjaro 5 mg/0.5 mL pens. This is a firm fixed-price delivery order with an ultimate completion date of July 30, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The award was made through open competition with no set-aside designation. This delivery order is issued under AmerisourceBergen Drug Corp's larger...
- The Defense Logistics Agency awarded a $1,632.54 firm fixed price delivery order to AmerisourceBergen Drug Corp on October 16, 2025, for Mounjaro 7.5 mg/0.5 ml pen (0.5 ml), a diabetes medication. The delivery order, which is unset-aside and competitively awarded, is scheduled for completion by October 17, 2025, with performance taking place at the contractor's facility in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract with...
- The Defense Logistics Agency awarded a $3,267.81 delivery order to AmerisourceBergen Drug Corp on August 28, 2025, for the supply of Mounjaro 7.5 mg/0.5 mL pens. The contract is a firm fixed price delivery order with an ultimate completion date of August 29, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. This award was competitively procured with no set-aside designation and represents a child contract under AmerisourceBergen's existing Indefinite...
- The Defense Logistics Agency awarded a $59,940.41 firm fixed-price delivery order to AmerisourceBergen Drug Corp on September 9, 2025, for the supply of Mounjaro 5 mg/0.5 mL pens. This is a non-set-aside competitive award with an ultimate completion date of September 10, 2025, and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical federal medical procurement vendor, fulfills...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 31, 2025, for the supply of Mounjaro 7.5 mg/0.5 mL pens valued at $2,614.05. This is a firm fixed-price delivery order with an ultimate completion date of August 1, 2025, and represents a non-set-aside competitive award. The place of performance is listed as AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded a $6,765.15 delivery order to AmerisourceBergen Drug Corp on August 25, 2025, for the supply of Mounjaro 5 mg/0.5 mL pens (0.5 mL) with an ultimate completion date of August 26, 2025. This is a firm fixed-price contract with no set-aside designation, competitively awarded through an open procurement process. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. As a child contract under a larger vehicle,...
- SPE2DB24D2212Indefinite Delivery Contract
- SPE2DB24D2212-SPE2DB25FHQLNDelivery Order
The Defense Logistics Agency awarded a $4,640.58 firm fixed price delivery order to AmerisourceBergen Drug Corp on August 4, 2025, for the supply of Mounjaro 5 mg/0.5 mL pens. This is a non-set-aside, competitively awarded contract with a completion date of August 5, 2025, and performance occurring at AmerisourceBergen's facility in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999,999,999 global pharmaceutical support vehicle valued through December 2026 that enables the company to supply an extensive range of pharmaceutical products and medical supplies to military healthcare programs worldwide. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical federal vendor, serves the Defense Health Agency and other government healthcare systems through its comprehensive contract vehicle. The company's federal procurement history demonstrates consistent delivery of diverse pharmaceutical products including specialty medications, vaccines, and medical supplies across multiple therapeutic domains. This delivery order for Mounjaro, a diabetes medication, reflects the company's ongoing role in supporting military and federal healthcare supply chains through the DLA's pharmaceutical prime vendor program.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $4.6k | 8/4/25 |